HeartBeam, Inc. (BEAT) vs MIRA Pharmaceuticals, Inc. (MIRA)
A side-by-side comparison of HeartBeam, Inc. and MIRA Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAT
HeartBeam, Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
MIRA
MIRA Pharmaceuticals, Inc.
$0.74HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — BEAT vs MIRA
growth of $100 · dividends reinvested · last 3yBEAT -74.6% (-36.7%/yr)MIRA -88.5% (-51.4%/yr)BEAT compounded faster over this window
BEAT MIRA
BEAT vs MIRA: by the numbers
- •BEAT is the larger company ($32M vs $31M market cap).
Metrics side by side
Valuation
| Metric | BEAT | MIRA |
|---|---|---|
| P/B ratio | 3.97 | 3.78 |
Profitability
| Metric | BEAT | MIRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -248.21% | -116.14% |
| ROIC | -249.58% | -115.18% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.